UCB And Microsoft Expand AI Tie-Up Beyond COVID-19
Merck KGaA Delves Into The Brain Itself
Two European pharmaceutical companies, UCB and Merck KGaA, are exploring artificial intelligence in different ways, the first for drug discovery and the second on a fundamental level.
